Traditionally, the mainstay of epilepsy therapy has been treatment with antiepileptic drugs (AEDs).

But for 30% of those affected, no combination of standard therapy — medications and/or surgery — can control their seizures.

Although more new AEDs have come to the market over the past 10 years than during any other time in history, their primary contribution has been to improve adverse effects of medication, rather than to make more people seizure-free.

The proportion of people with epilepsy worldwide — whose seizures cannot be controlled by medical therapy — has remained unchanged, despite all these new pharmaceutical interventions.

And as this search for better medications and surgical approaches continues, anotheravenue of epilepsy treatment is now gaining momentum, designed to predict, detect, prevent, and abort seizures.

It’s only recently that Neuroengineering first appeared.

Neuroengineering is a discipline at the frontier between neuroscience and engineering.

It encompasses experimental, computational, theoretical, clinical…